ST6GAL2 and central nervous system cancer: We further determined that higher levels of ST6GAL1 or lower levels of ST6Gal2 correlated with worse glioma patient survival, but there was no difference in survival with a similar mRNA cutoff in only GBM patients (Supplemental Figure 2, H and I; and data not shown).